Pladienolide B

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Pladienolide B  纯度: ≥98.0%

Pladienolide B 是一种有效的癌细胞生长抑制剂,其作用靶向剪接体的 SF3B1 亚单位。Pladienolide B 通过抑制前 mRNA 剪接发挥抗肿瘤作用,诱导调亡。

Pladienolide B

Pladienolide B Chemical Structure

CAS No. : 445493-23-2

规格 价格 是否有货 数量
100 μg ¥5500 In-stock

* Please select Quantity before adding items.

生物活性

Pladienolide B is a potent cancer cell growth inhibitor that targets the SF3B1 subunit of the spliceosome. Pladienolide B exerts antitumor activities mediated through the inhibition of pre-mRNA splicing. Pladienolide B induces apoptosis[1][2][3].

体外研究
(In Vitro)

Pladienolide B (0.1-2 nM; 24-72 hours) inhibits human cervical carcinoma cells viability[3].
Pladienolide B (0.1-2 nM; 24-48 hours) reduces SF3b1 expression in human cervical carcinoma cells[3].
Pladienolide B induces (0.1-2 nM; 24 hours) cell cycle arrest and apoptosis[3].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[3]

Cell Line: HeLa cells
Concentration: 0.1, 0.5, 1, 1.5, 2 nM
Incubation Time: 24, 48, 72 hours
Result: Significantly decreased cell viability, and the decrease was concentration- and time-dependent.

Apoptosis Analysis[3]

Cell Line: HeLa cells
Concentration: 0.1, 0.5, and 2 nM
Incubation Time: 24 hours
Result: The apoptotic cells were highly induced at 24 hours.

RT-PCR[3]

Cell Line: HeLa cells
Concentration: 0.1, 0.5, and 2 nM
Incubation Time: 24, 48 hours
Result: Induced a time- and concentration-dependent decrease in cellular SF3b1 proteins.

体内研究
(In Vivo)

Pladienolide B (2.5-10 mg/kg; i.v.; daily for 5 days) has strong antitumor activities[4].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female or male BALB/c nu/nu mice (7 weeks of age) (PC-3, OVCAR-3, DU-145, WiDr, and HCT-116, BSY-1 xenografts)[4]
Dosage: 2.5, 5, and 10 mg/kg
Administration: I.v.; daily for 5 days
Result: Showed strong growth inhibitory or regressive activities against these xenografts.

分子量

536.70

Formula

C30H48O8

CAS 号

445493-23-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Pure form -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
参考文献
  • [1]. Effenberger KA, et al. Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs. J Biol Chem. 2014 Jan 24;289(4):1938-47.

    [2]. Aouida M, et al. CRISPR/Cas9-mediated target validation of the splicing inhibitor Pladienolide B. Biochim Open. 2016 Feb 24;3:72-75.

    [3]. Zhang Q, et al. Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1273-1280.

    [4]. Mizui Y, et al. Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities. J Antibiot (Tokyo). 2004 Mar;57(3):188-96.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务